Clinical trial
Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
NCT00272844 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 1998
- Completion date
- July 31, 2011
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.